Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 75,000 shares at $40.91 ($3.1M) on 2017-10-05, disclosed to the SEC on 2017-10-06.
Open-market sale of $3.1M ACAD by EVP AND GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.91 | 37,500 | $1.5M | 50.0% |
| 2 | $40.91 | 37,500 | $1.5M | 50.0% |
| Total | $40.91 avg | 75,000 | $3.1M | 100% |
| Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |
| ACAD | SELL | 2017-07-21 | $1.1M | — | Filing → |